These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9571386)

  • 21. Predicting methadone maintenance treatment outcomes using the Addiction Severity Index and the MMPI-2 Content Scales (Negative Treatment Indicators and Cynism scales).
    Craig RJ; Olson RE
    Am J Drug Alcohol Abuse; 2004 Nov; 30(4):823-39. PubMed ID: 15624551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).
    Roux P; Lions C; Vilotitch A; Michel L; Mora M; Maradan G; Marcellin F; Spire B; Morel A; Carrieri PM;
    Harm Reduct J; 2016 Apr; 13():12. PubMed ID: 27048152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desipramine treatment for cocaine dependence. Role of antisocial personality disorder.
    Arndt IO; McLellan AT; Dorozynsky L; Woody GE; O'Brien CP
    J Nerv Ment Dis; 1994 Mar; 182(3):151-6. PubMed ID: 8113775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors in Buprenorphine- versus methadone-maintained patients.
    Schottenfeld RS; Pakes JR; Kosten TR
    J Nerv Ment Dis; 1998 Jan; 186(1):35-43. PubMed ID: 9457145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to methadone maintenance and counseling in antisocial patients with and without major depression.
    Alterman AI; Rutherford MJ; Cacciola JS; McKay JR; Woody GE
    J Nerv Ment Dis; 1996 Nov; 184(11):695-702. PubMed ID: 8955683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Psychopathy and associated personality disorders: searching for a particular effect of the borderline personality disorder?].
    Nioche A; Pham TH; Ducro C; de Beaurepaire C; Chudzik L; Courtois R; Réveillère C
    Encephale; 2010 Jun; 36(3):253-9. PubMed ID: 20620268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inpatient opiate detoxification in Geneva: follow-up at 1 and 6 months.
    Broers B; Giner F; Dumont P; Mino A
    Drug Alcohol Depend; 2000 Feb; 58(1-2):85-92. PubMed ID: 10669058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contribution of dissociative symptoms to antisocial behavior in a sample of high-school students].
    Chabrol H; Saint-Martin C; Sejourné N; Moyano O
    Encephale; 2009 Feb; 35(1):52-6. PubMed ID: 19250994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desipramine treatment of cocaine dependence in methadone-maintained patients.
    Arndt IO; Dorozynsky L; Woody GE; McLellan AT; O'Brien CP
    Arch Gen Psychiatry; 1992 Nov; 49(11):888-93. PubMed ID: 1444727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative modeling of client engagement and outcomes during the first 6 months of methadone treatment.
    Joe GW; Simpson DD; Greener JM; Rowan-Szal GA
    Addict Behav; 1999; 24(5):649-59. PubMed ID: 10574302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personality disorders and treatment outcome in methadone maintenance patients.
    Cacciola JS; Rutherford MJ; Alterman AI; McKay JR; Snider EC
    J Nerv Ment Dis; 1996 Apr; 184(4):234-9. PubMed ID: 8604033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
    Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
    JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment].
    Fernández Miranda J; González García-Portilla M; Sáiz Martínez P; Gutiérrez Cienfuegos E; Bobes García J
    Actas Esp Psiquiatr; 2001; 29(4):228-32. PubMed ID: 11470057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative urine drug monitoring in methadone programs: potential clinical uses.
    McCarthy J
    J Psychoactive Drugs; 1994; 26(2):199-206. PubMed ID: 7931864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment.
    Giacomuzzi SM; Ertl M; Kemmler G; Riemer Y; Vigl A
    ScientificWorldJournal; 2005 May; 5():452-68. PubMed ID: 15925962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts.
    Petrakis I; Carroll KM; Nich C; Gordon L; Kosten T; Rounsaville B
    Drug Alcohol Depend; 1998 May; 50(3):221-6. PubMed ID: 9649975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antisocial personality disorder and cocaine dependence: their effects on behavioral and electroencephalographic measures of time estimation.
    Bauer LO
    Drug Alcohol Depend; 2001 Jun; 63(1):87-95. PubMed ID: 11297834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive validity of the PCL-R for offenders with intellectual disability in a high security hospital: treatment progress.
    Morrissey C; Mooney P; Hogue TE; Lindsay WR; Taylor JL
    J Intellect Dev Disabil; 2007 Jun; 32(2):125-33. PubMed ID: 17613683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers.
    Brooner RK; King VL; Kidorf M; Schmidt CW; Bigelow GE
    Arch Gen Psychiatry; 1997 Jan; 54(1):71-80. PubMed ID: 9006403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.